Literature DB >> 27057068

Novel anticancer nanogel conjugates of activated nucleoside analogs.

Thulani H Senanayake1, Galya Warren1, Serguei V Vinogradov1.   

Abstract

Entities:  

Year:  2011        PMID： 27057068      PMCID： PMC4821545     

Source DB:  PubMed          Journal:  Polymer Prepr        ISSN： 0032-3934


× No keyword cloud information.
  7 in total

1.  Studies on polynucleotides. III. Enzymic degradation; substrate specificity and properties of snake venom phosphodiesterase.

Authors:  W E RAZZELL; H G KHORANA
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

Review 2.  Liposomal, nanoparticle, and conjugated formulations of anticancer agents.

Authors:  William C Zamboni
Journal:  Clin Cancer Res       Date:  2005-12-01       Impact factor: 12.531

3.  Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.

Authors:  Tomonori Nochi; Yoshikazu Yuki; Haruko Takahashi; Shin-ichi Sawada; Mio Mejima; Tomoko Kohda; Norihiro Harada; Il Gyu Kong; Ayuko Sato; Nobuhiro Kataoka; Daisuke Tokuhara; Shiho Kurokawa; Yuko Takahashi; Hideo Tsukada; Shunji Kozaki; Kazunari Akiyoshi; Hiroshi Kiyono
Journal:  Nat Mater       Date:  2010-06-20       Impact factor: 43.841

4.  Methanol esterification reactions catalyzed by snake venom and bovine intestinal 5'-nucleotide phosphodiesterases. Formation of nucleoside 5'-monophosphate methyl esters from guanosine 5'-triphosphate and other nucleoside 5'-polyphosphates.

Authors:  M Garcia-Diaz; M Avalos; J C Cameselle
Journal:  Eur J Biochem       Date:  1991-03-14

Review 5.  Nucleoside analogues and nucleobases in cancer treatment.

Authors:  Carlos M Galmarini; John R Mackey; Charles Dumontet
Journal:  Lancet Oncol       Date:  2002-07       Impact factor: 41.316

6.  Inhibition of herpes simplex virus 1 reproduction with hydrophobized antisense oligonucleotides.

Authors:  S V Vinogradov; Y Suzdaltseva; A V Kabanov
Journal:  Biochem Biophys Res Commun       Date:  1994-09-15       Impact factor: 3.575

7.  In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.

Authors:  Carlos M Galmarini; Xavier Thomas; Fabien Calvo; Philippe Rousselot; Muriel Rabilloud; Assia El Jaffari; Emeline Cros; Charles Dumontet
Journal:  Br J Haematol       Date:  2002-06       Impact factor: 6.998
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.